Metadata Search
Allos Therapeutics
Page 1 of 23 results
Sort by: relevance publication year Download as CSV

Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia

Journal Article published Jun 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 6 on pages 1024 to 1029

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | Leukemia and Lymphoma Society | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases (U24-CA076518) | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | U.S. Department of Health and Human Services (HHSH250201200016C) | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Terumo BCT | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Milliman | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Reinhold Munker, Ruta Brazauskas, Hai Lin Wang, Marcos de Lima, Hanna J. Khoury, Robert Peter Gale, Richard T. Maziarz, Brenda M. Sandmaier, Daniel Weisdorf, Wael Saber

New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation

Journal Article published Apr 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 4 on pages 768 to 770

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (HHSH250201200016C) | U.S. Public Health Service (U24-CA076518) | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | Leukemia and Lymphoma Society | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases (5U10HL069294) | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Terumo BCT | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (N00014-13-1-0039, N00014-14-1-0028) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Institutional Research | Milliman | Office of Naval Research | Chimerix, Inc. | Jeff Gordon Children's Foundation | American Cancer Society (86-004-26) | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Anita D'Souza, Jiaxing Huang, Parameswaran Hari

Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation

Journal Article published 15 Mar 2016 in British Journal of Haematology volume 174 issue 2 on pages 235 to 248

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (U24-CA076518) | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | TerumoBCT | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | National Institute of Allergy and Infectious Diseases (5U10HL069294) | Sanofi US | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | Genentech | Genzyme | Miltenyi Biotec, Inc. | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Tarix Pharmaceuticals | Amgen | HistoGenetics, Inc. | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Timothy S. Fenske, Kwang W. Ahn, Tara M. Graff, Alyssa DiGilio, Qaiser Bashir, Rammurti T. Kamble, Ernesto Ayala, Ulrike Bacher, Jonathan E. Brammer, Mitchell Cairo, Andy Chen, Yi-Bin Chen, Saurabh Chhabra, Anita D'Souza, Umar Farooq, Cesar Freytes, Siddhartha Ganguly, Mark Hertzberg, David Inwards, Samantha Jaglowski, Mohamed A. Kharfan-Dabaja, Hillard M. Lazarus, Sunita Nathan, Attaphol Pawarode, Miguel-Angel Perales, Nishitha Reddy, Sachiko Seo, Anna Sureda, Sonali M. Smith, Mehdi Hamadani

Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell Transplantation

Journal Article published Sep 2015 in Biology of Blood and Marrow Transplantation volume 21 issue 9 on pages 1679 to 1686

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (P30 CA016056, U24-CA076518) | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (R01 HL102278, 5U10HL069294) | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Terumo BCT | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | The Medical College of Wisconsin | Otsuka America Pharmaceutical | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Office of Naval Research (N00014-12-1-0142, N00014-13-1-0039) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Theresa Hahn, Lara E. Sucheston-Campbell, Leah Preus, Xiaochun Zhu, John A. Hansen, Paul J. Martin, Li Yan, Song Liu, Stephen Spellman, David Tritchler, Alyssa Clay, Kenan Onel, Marcelo Pasquini, Philip L. McCarthy

Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure

Journal Article published 12 Apr 2018 in Cancer volume 124 issue 12 on pages 2541 to 2551

Research funded by Amgen, Inc (corporate member) | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (U24 CA076518) | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | PerkinElmer, Inc | Leukemia and Lymphoma Society | Fresenius-Biotech North America, Inc | Therakos | Fred Hutchinson Cancer Research Center | Actinium Pharmaceuticals, Inc | Gentium SpA | WellPoint | Optum Healthcare Solutions, Inc | Seattle Genetics | National Institute of Allergy and Infectious Diseases | Sanofi US | University of Utah | U.S. Department of Defense | Gamida Cell Teva Joint Venture, Ltd | HistoGenetics, Inc | University of Minnesota | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Stemsoft Software, Inc | National Institutes of Health | Osiris Therapeutics | Otsuka America Pharmaceutical, Inc | Genentech | Soligenix, Inc | Teva Neuroscience, Inc | Terumo BCT | Genzyme | Public Health Service (U24-CA076518) | Miltenyi Biotec, Inc | Health Resources and Services Administration (HHSH250201200016C) | Celgene | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc | Jeff Gordon Children's Foundation | Department of the Navy | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Remedy Informatics

Authors: Sonali M. Smith, James Godfrey, Kwang Woo Ahn, Alyssa DiGilio, Sairah Ahmed, Vaibhav Agrawal, Veronika Bachanova, Ulrike Bacher, Asad Bashey, Javier Bolaños-Meade, Mitchell Cairo, Andy Chen, Saurabh Chhabra, Edward Copelan, Parastoo B. Dahi, Mahmoud Aljurf, Umar Farooq, Siddhartha Ganguly, Mark Hertzberg, Leona Holmberg, David Inwards, Abraham S. Kanate, Reem Karmali, Vaishalee P. Kenkre, Mohamed A. Kharfan-Dabaja, Andreas Klein, Hillard M. Lazarus, Matthew Mei, Alberto Mussetti, Taiga Nishihori, Praveen Ramakrishnan Geethakumari, Ayman Saad, Bipin N. Savani, Harry C. Schouten, Nirav Shah, Alvaro Urbano-Ispizua, Ravi Vij, Julie Vose, Anna Sureda, Mehdi Hamadani

Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network

Journal Article published 19 Apr 2018 in British Journal of Haematology volume 181 issue 6 on pages 760 to 769

Research funded by Fondazione Cassa di Risparmio di Modena | Associazione Angela Serra per la Ricerca sul Cancro | Fondazione Italiana Linfomi | Allos Therapeutics | AIRC 5x1000 (10007) | NIH/NCI CCSG (P30 CA008748)

Authors: Massimo Federico, Monica Bellei, Luigi Marcheselli, Marc Schwartz, Martina Manni, Vittoria Tarantino, Stefano Pileri, Young-Hyeh Ko, Maria E. Cabrera, Steven Horwitz, Won S. Kim, Andrei Shustov, Francine M. Foss, Arnon Nagler, Kenneth Carson, Lauren C. Pinter-Brown, Silvia Montoto, Michele Spina, Tatyana A. Feldman, Mary J. Lechowicz, Sonali M. Smith, Frederick Lansigan, Raul Gabus, Julie M. Vose, Ranjana H. Advani, the T cell Project Network

The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia

Journal Article published Jul 2015 in Biology of Blood and Marrow Transplantation volume 21 issue 7 on pages 1251 to 1257

Research funded by Medac GmbH | Kiadis Pharma | National Cancer Institute (U24-CA076518) | Sigma-Tau Pharmaceuticals | StemCyte | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | National Institute of Allergy and Infectious Diseases | Sanofi US | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Terumo BCT | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | The Medical College of Wisconsin | NCI | Otsuka America Pharmaceutical | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Tarix Pharmaceuticals | Amgen | Office of Naval Research (N00014-12-1-0142, N00014-13-1-0039) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Jennifer L. Holter-Chakrabarty, Namali Pierson, Mei-Jie Zhang, Xiaochun Zhu, Görgün Akpek, Mahmoud D. Aljurf, Andrew S. Artz, Frédéric Baron, Christopher N. Bredeson, Christopher C. Dvorak, Robert B. Epstein, Hillard M. Lazarus, Richard F. Olsson, George B. Selby, Kirsten M. Williams, Kenneth R. Cooke, Marcelo C. Pasquini, Philip L. McCarthy

Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma

Journal Article published Jan 2017 in Biology of Blood and Marrow Transplantation volume 23 issue 1 on pages 60 to 66

Research funded by Medac GmbH | Kiadis Pharma | Takeda Oncology | Sigma-Tau Pharmaceuticals | StemCyte | TerumoBCT | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | Ariad Pharmaceuticals | University of Utah | NHLBI and NCI (5U10HL069294) | Health Research, Inc. Roswell Park Cancer Institute | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | Genentech | Genzyme | Miltenyi Biotec, Inc. | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID) (U24-CA076518) | The Medical College of Wisconsin | Otsuka America Pharmaceutical | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | HistoGenetics, Inc. | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Robert F. Cornell, Veronika Bachanova, Anita D'Souza, Kwang Woo-Ahn, Michael Martens, Jiaxing Huang, A. Samer Al-Homsi, Saurabh Chhabra, Edward Copelan, Miguel-Angel Diaz, Cesar O. Freytes, Robert Peter Gale, Siddhartha Ganguly, Mehdi Hamadani, Gerhard Hildebrandt, Rammurti T. Kamble, Mohamed Kharfan-Dabaja, Tamila Kindwall-Keller, Hillard M. Lazarus, David I. Marks, Taiga Nishihori, Richard F. Olsson, Ayman Saad, Saad Usmani, David H. Vesole, Jean Yared, Tomer Mark, Yago Nieto, Parameswaran Hari

European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards

Journal Article published Mar 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 3 on pages 514 to 519

Research funded by National Cancer Institute | National Heart, Lung, and Blood Institute | National Institute of Allergy and Infectious Diseases | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Actinium Pharmaceuticals | Allos Therapeutics | Amgen

Authors: Chloe Anthias, Paul V. O'Donnell, Deidre M. Kiefer, Jean Yared, Maxim Norkin, Paolo Anderlini, Bipin N. Savani, Miguel A. Diaz, Menachem Bitan, Joerg P. Halter, Brent R. Logan, Galen E. Switzer, Michael A. Pulsipher, Dennis L. Confer, Bronwen E. Shaw

Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis

Journal Article published May 2017 in Biology of Blood and Marrow Transplantation volume 23 issue 5 on pages 853 to 856

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | TerumoBCT | Leukemia and Lymphoma Society | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | Ariad Pharmaceuticals | University of Utah | NHLBI and NCI (5U10HL069294) | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID) (U24-CA076518) | Otsuka America Pharmaceutical | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Milliman | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Mehdi Hamadani, Abraham S. Kanate, Alyssa DiGilio, Kwang Woo Ahn, Sonali M. Smith, Jong Wook Lee, Ernesto Ayala, Nelson Chao, Parameswaran Hari, Javier Bolaños-Meade, Ronald Gress, Niels Smedegaard Anderson, Yi-Bin Chen, Umar Farooq, Gary Schiller, Jean Yared, Anna Sureda, Timothy S. Fenske, Horatiu Olteanu

Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers

Journal Article published Mar 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 3 on pages 520 to 527

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (U24-CA076518) | U.S. Public Health Service | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | TerumoBCT | Leukemia and Lymphoma Society | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Milliman | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Chloe Anthias, Bronwen E. Shaw, Deidre M. Kiefer, Jane L. Liesveld, Jean Yared, Rammurti T. Kamble, Anita D'Souza, Peiman Hematti, Matthew D. Seftel, Maxim Norkin, Zachariah DeFilipp, Kimberly A. Kasow, Muneer H. Abidi, Bipin N. Savani, Nirali N. Shah, Paolo Anderlini, Miguel A. Diaz, Adriana K. Malone, Joerg P. Halter, Hillard M. Lazarus, Brent R. Logan, Galen E. Switzer, Michael A. Pulsipher, Dennis L. Confer, Paul V. O'Donnell

In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children

Journal Article published Dec 2015 in Biology of Blood and Marrow Transplantation volume 21 issue 12 on pages 2173 to 2179

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (U24-CA076518) | U.S. Public Health Service | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | Medical College of Wisconsin | TerumoBCT | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Milliman | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Doris M. Ponce, Mary Eapen, Rodney Sparapani, Tracey A. O'Brien, Ka Wah Chan, Junfang Chen, John Craddock, Kirk R. Schultz, John E. Wagner, Miguel-Angel Perales, Juliet N. Barker

Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies

Journal Article published Feb 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 2 on pages 248 to 257

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (U24-CA076518) | Roswell Park Cancer Institute | Takeda Oncology | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | TerumoBCT | Leukemia and Lymphoma Society | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Miltenyi Biotec | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Milliman | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Marcelo C. Pasquini, Mei-Jie Zhang, Bruno C. Medeiros, Philippe Armand, Zhen-Huan Hu, Taiga Nishihori, Mahmoud D. Aljurf, Görgün Akpek, Jean-Yves Cahn, Mitchell S. Cairo, Jan Cerny, Edward A. Copelan, Abhinav Deol, César O. Freytes, Robert Peter Gale, Siddhartha Ganguly, Biju George, Vikas Gupta, Gregory A. Hale, Rammurti T. Kamble, Thomas R. Klumpp, Hillard M. Lazarus, Selina M. Luger, Jane L. Liesveld, Mark R. Litzow, David I. Marks, Rodrigo Martino, Maxim Norkin, Richard F. Olsson, Betul Oran, Attaphol Pawarode, Michael A. Pulsipher, Muthalagu Ramanathan, Ran Reshef, Ayman A. Saad, Wael Saber, Bipin N. Savani, Harry C. Schouten, Olle Ringdén, Martin S. Tallman, Geoffrey L. Uy, William A. Wood, Baldeep Wirk, Waleska S. Pérez, Minoo Batiwalla, Daniel J. Weisdorf

Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research

Journal Article published Dec 2015 in Biology of Blood and Marrow Transplantation volume 21 issue 12 on pages 2154 to 2159

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (U24-CA076518, HHSH250201200016) | U.S. Public Health Service | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | TerumoBCT | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration | Celgene | Leukemia and Lymphoma Society of Canada | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Milliman | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Michael J. Burke, Michael R. Verneris, Jennifer Le Rademacher, Wensheng He, Hisham Abdel-Azim, Allistair A. Abraham, Jeffery J. Auletta, Mouhab Ayas, Valerie I. Brown, Mitchell S. Cairo, Ka Wah Chan, Miguel A. Diaz Perez, Christopher C. Dvorak, R. Maarten Egeler, Lamis Eldjerou, Haydar Frangoul, Gregory M.T. Guilcher, Robert J. Hayashi, Ahmed Ibrahim, Kimberly A. Kasow, Wing H. Leung, Richard F. Olsson, Michael A. Pulsipher, Niketa Shah, Nirali N. Shah, Elizabeth Thiel, Julie-An Talano, Carrie L. Kitko

Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure

Journal Article published Oct 2015 in Biology of Blood and Marrow Transplantation volume 21 issue 10 on pages 1790 to 1795

Research funded by Medac GmbH | Milliman USA, Inc | Kiadis Pharma | National Cancer Institute (U24-CA076518) | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | PerkinElmer, Inc | Fresenius-Biotech North America, Inc | Actinium Pharmaceuticals | Therakos | Gamida Cell Teva Joint Venture Ltd | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Optum Healthcare Solutions, Inc | Seattle Genetics | National Institute of Allergy and Infectious Diseases | Sanofi US | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Onyx Pharmaceuticals | Millennium: The Takeda Oncology Co | Blue Cross and Blue Shield Association | Health Research, Inc, Roswell Park Cancer Institute | National Heart, Lung, and Blood Institute (5U10HL069294) | Miltenyi Biotec | Stemsoft Software, Inc | Osiris Therapeutics | HistoGenetics | Otsuka America Pharmaceutical, Inc | Genentech | Soligenix, Inc | Teva Neuroscience, Inc | Terumo BCT | Genzyme | Incyte Corp | The Medical College of Wisconsin | NCI | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc | Jeff Gordon Children's Foundation | Allos Therapeutics | GlaxoSmithKline | Remedy Informatics

Authors: Mouhab Ayas, Mary Eapen, Jennifer Le-Rademacher, Jeanette Carreras, Hisham Abdel-Azim, Blanche P. Alter, Paolo Anderlini, Minoo Battiwalla, Marc Bierings, David K. Buchbinder, Carmem Bonfim, Bruce M. Camitta, Anders L. Fasth, Robert Peter Gale, Michelle A. Lee, Troy C. Lund, Kasiani C. Myers, Richard F. Olsson, Kristin M. Page, Tim D. Prestidge, Mohamed Radhi, Ami J. Shah, Kirk R. Schultz, Baldeep Wirk, John E. Wagner, H. Joachim Deeg

Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia

Journal Article published Oct 2015 in Biology of Blood and Marrow Transplantation volume 21 issue 10 on pages 1776 to 1782

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (U24-CA076518) | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | National Institute of Allergy and Infectious Diseases | Sanofi US | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Terumo BCT | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | The Medical College of Wisconsin | Otsuka America Pharmaceutical | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Yoshihiro Inamoto, Mary E.D. Flowers, Tao Wang, Alvaro Urbano-Ispizua, Michael T. Hemmer, Corey S. Cutler, Daniel R. Couriel, Amin M. Alousi, Joseph H. Antin, Robert Peter Gale, Vikas Gupta, Betty K. Hamilton, Mohamed A. Kharfan-Dabaja, David I. Marks, Olle T.H. Ringdén, Gérard Socié, Melhem M. Solh, Görgün Akpek, Mitchell S. Cairo, Nelson J. Chao, Robert J. Hayashi, Taiga Nishihori, Ran Reshef, Ayman Saad, Ami Shah, Takanori Teshima, Martin S. Tallman, Baldeep Wirk, Stephen R. Spellman, Mukta Arora, Paul J. Martin

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen

Journal Article published Oct 2015 in Biology of Blood and Marrow Transplantation volume 21 issue 10 on pages 1746 to 1753

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (U24-CA076518) | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | National Institute of Allergy and Infectious Diseases | Sanofi US | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Terumo BCT | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | The Medical College of Wisconsin | Otsuka America Pharmaceutical | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Office of Naval Research (N00014-12-1-0142, N00014-13-1-0039) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Alvaro Urbano-Ispizua, Steven Z. Pavletic, Mary E. Flowers, John P. Klein, Mei-Jie Zhang, Jeanette Carreras, Silvia Montoto, Miguel-Angel Perales, Mahmoud D. Aljurf, Görgün Akpek, Christopher N. Bredeson, Luciano J. Costa, Christopher Dandoy, César O. Freytes, Henry C. Fung, Robert Peter Gale, John Gibson, Mehdi Hamadani, Robert J. Hayashi, Yoshihiro Inamoto, David J. Inwards, Hillard M. Lazarus, David G. Maloney, Rodrigo Martino, Reinhold Munker, Taiga Nishihori, Richard F. Olsson, David A. Rizzieri, Ran Reshef, Ayman Saad, Bipin N. Savani, Harry C. Schouten, Sonali M. Smith, Gérard Socié, Baldeep Wirk, Lolie C. Yu, Wael Saber

Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation

Journal Article published Sep 2015 in Biology of Blood and Marrow Transplantation volume 21 issue 9 on pages 1589 to 1596

Research funded by Medac GmbH | Kiadis Pharma | National Cancer Institute (U24-CA076518) | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | National Institute of Allergy and Infectious Diseases | Sanofi US | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Terumo BCT | Genzyme | Teva Neuroscience, Inc. | NMDP | Stemsoft Software, Inc. | Health Research | The Medical College of Wisconsin | Otsuka America Pharmaceutical | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Ronald M. Sobecks, Tao Wang, Medhat Askar, Meighan M. Gallagher, Michael Haagenson, Stephen Spellman, Marcelo Fernandez-Vina, Karl-Johan Malmberg, Carlheinz Müller, Minoo Battiwalla, James Gajewski, Michael R. Verneris, Olle Ringdén, Susana Marino, Stella Davies, Jason Dehn, Martin Bornhäuser, Yoshihiro Inamoto, Ann Woolfrey, Peter Shaw, Marilyn Pollack, Daniel Weisdorf, Jeffrey Milller, Carolyn Hurley, Stephanie J. Lee, Katharine Hsu

Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial

Journal Article published Oct 2015 in Biology of Blood and Marrow Transplantation volume 21 issue 10 on pages 1815 to 1822

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | National Institute of Allergy and Infectious Diseases | Sanofi US | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (U10HL069294, 5U10HL069294) | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Terumo BCT | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | The Medical College of Wisconsin | NCI (U24-CA076518) | Otsuka America Pharmaceutical | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Office of Naval Research (N00014-12-1-0142, N00014-13-1-0039) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Department of the Navy | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Nandita Khera, Navneet S. Majhail, Ruta Brazauskas, Zhiwei Wang, Naya He, Mahmoud D. Aljurf, Görgün Akpek, Yoshiko Atsuta, Sara Beattie, Christopher N. Bredeson, Linda J. Burns, Jignesh D. Dalal, César O. Freytes, Vikas Gupta, Yoshihiro Inamoto, Hillard M. Lazarus, Charles F. LeMaistre, Amir Steinberg, David Szwajcer, John R. Wingard, Baldeep Wirk, William A. Wood, Steven Joffe, Theresa E. Hahn, Fausto R. Loberiza, Claudio Anasetti, Mary M. Horowitz, Stephanie J. Lee

Autologous/Allogeneic Hematopoietic Cell Transplantation versus Tandem Autologous Transplantation for Multiple Myeloma: Comparison of Long-Term Postrelapse Survival

Journal Article published Mar 2018 in Biology of Blood and Marrow Transplantation volume 24 issue 3 on pages 478 to 485

Research funded by National Cancer Institute (U24-CA076518) | National Heart, Lung, and Blood Institute (5U10HL069294) | National Institute of Allergy and Infectious Diseases | Health Resources and Services Administration (HHSH250201200016C) | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Actinium Pharmaceuticals | Allos Therapeutics | Amgen

Authors: Myo Htut, Anita D'Souza, Amrita Krishnan, Benedetto Bruno, Mei-Jie Zhang, Mingwei Fei, Miguel Angel Diaz, Edward Copelan, Siddhartha Ganguly, Mehdi Hamadani, Mohamed Kharfan-Dabaja, Hillard Lazarus, Cindy Lee, Kenneth Meehan, Taiga Nishihori, Ayman Saad, Sachiko Seo, Muthalagu Ramanathan, Saad Z. Usmani, Christina Gasparetto, Tomer M. Mark, Yago Nieto, Parameswaran Hari